FO
ESPR

FT Options’s Esperion Therapeutics ESPR Stock Holding History

FT Options’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-24,100
Closed -$16K – 214
2017
Q1 		$16K Buy
+24,100
New +$552K 0.02% 208
2016
Q4 		– Sell
-110,600
Closed -$421K – 284
2016
Q3 		$421K Buy
110,600
+25,100
+29% +$284K 0.33% 62
2016
Q2 		$195K Sell
85,500
-6,700
-7% -$111K 0.17% 107
2016
Q1 		$117K Buy
92,200
+82,200
+822% +$1.32M 0.12% 116
2015
Q4 		$50K Buy
+10,000
New +$252K 0.04% 154

Other funds holding ESPR

MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return